Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines

DOSTÁLOVÁ, H., R. JORDA, E. ŘEZNÍČKOVÁ, V. KRYŠTOF
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,  PDF.